Accelerator

IHH Catalyst | North Asia Edition

A programme by IHH Healthcare

A three-month hybrid programme in Hong Kong and Chinese Mainland that pilots healthcare startups in live hospital settings. Applications for the 2026 call have closed.

At a glance

Best forHealthcare startups with pilot-ready solutions and a planned or existing presence in Hong Kong or Shanghai.
StageGrowth
Duration3 months
FormatHybrid
Run withGleneagles Hong Kong, Parkway Shanghai

About IHH Catalyst | North Asia Edition

IHH Catalyst North Asia Edition runs with IHH's subsidiaries Gleneagles Hong Kong and Parkway Shanghai. IHH announced the 2026 call on 27 July 2026. The programme is aimed at early-growth to enterprise-ready companies whose solutions are ready for pilots, proof-of-concepts and broader deployment in hospital systems.

What you get

  • Mentorship from leaders, clinicians and functional experts at IHH, Gleneagles Hong Kong and Parkway Shanghai
  • Opportunities to pilot and validate solutions in live hospital environments
  • Support on regulatory readiness, data protection, cybersecurity and interoperability
  • Routes toward long-term partnerships, scale-up and potential investment

Who can apply

  • Startups with solutions ready for pilots, proof-of-concepts or broader deployment in hospital systems
  • Selection requires an existing or planned operational presence in Hong Kong or Shanghai

How selection works: The cohort announcement was set for 11 September 2026. The Demo Day is set for Hong Kong on 26 January 2027.

How to apply: A partner listing reports that applications for this call have closed. Check IHH's newsroom for the next call.

Where to apply

Other IHH Healthcare programmes

Everything about IHH Healthcare